Advanced search

News (105)

Scott+Scott Attorneys at Law LLP & Hedin Hall LLP Announce Notice of Class Action and Proposed Settlement to All Who Purchased or Acquired Shares of Viatris Inc. Pursuant to a November 2020 Merger of Mylan N.V. and Upjohn, Inc. to Form Viatris	Mar. 11	PR
Scott+Scott Attorneys at Law LLP & Hedin Hall LLP Announce Notice of Class Action and Proposed Settlement to All Who Purchased or Acquired Shares of Viatris Inc. Pursuant to a November 2020 Merger of Mylan N.V. and Upjohn, Inc. to Form Viatris	Mar. 11	BU
Transcript : Viatris Inc., 2023 Earnings Call, Feb 28, 2024	Feb. 28
Viatris Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance	Feb. 28	PR
Transcript : Viatris Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-10-2024 10:30 AM	Jan. 10
Viatris to Participate in 42nd Annual J.P. Morgan Healthcare Conference	Dec. 21	PR
Drugmaker Viatris appoints Theodora Mistras as CFO	Dec. 15	RE
Viatris Continues its Preparations for Phase 2 of its Strategic Plan by Announcing the Appointment of Theodora "Doretta" Mistras as Chief Financial Officer, Effective March 1, 2024, and Philippe Martin as Chief R&D Officer	Dec. 15	PR
Viatris Announces CFO Changes	Dec. 14	CI
Transcript : Viatris Inc. Presents at 14th Annual Jefferies London Healthcare Conference 2023, Nov-15-2023 09:30 AM	Nov. 15
Viatris to Participate in the Jefferies London Healthcare Conference	Nov. 14	PR
Transcript : Viatris Inc., Q3 2023 Earnings Call, Nov 07, 2023	Nov. 07
Viatris Reports Strong Financial and Operational Results for the Third Quarter 2023 and Reaffirms Full-Year 2023 Adjusted EBITDA and Free Cash Flow Guidance Ranges[1]	Nov. 07	PR
Viatris to Release Third Quarter 2023 Financial Results on November 7, 2023	23-10-10	PR
Transcript : Viatris Inc., Q2 2023 Earnings Call, Aug 07, 2023	23-08-07
Viatris Reports Strong Financial and Operational Results for Second Quarter 2023 and Reaffirms Full-Year 2023 Guidance Ranges[1]	23-08-07	PR
Viatris to Report Second Quarter 2023 Financial Results on August 7, 2023	23-06-28	PR
Transcript : Viatris Inc. Presents at Goldman Sachs 44th Annual Global Healthcare Conference, Jun-13-2023 01:20 PM	23-06-13
Viatris to Participate in Goldman Sachs 44th Annual Global Healthcare Conference	23-05-17	PR
Transcript : Viatris Inc., Q1 2023 Earnings Call, May 08, 2023	23-05-08
Viatris Reports Strong Financial and Operational Results for First Quarter 2023 and Reaffirms Full-Year 2023 Guidance Ranges[1]	23-05-08	PR
Viatris to Report First Quarter 2023 Financial Results on May 8, 2023	23-04-12	PR
Transcript : Viatris Inc., Q4 2022 Earnings Call, Feb 27, 2023	23-02-27
Viatris Announces Appointment of Scott A. Smith as CEO Effective April 1, 2023	23-02-27	PR
Viatris Reports Strong Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Financial Guidance	23-02-27	PR
Viatris to Report Fourth Quarter and Full Year 2022 Financial Results on February 27, 2023	23-02-15	PR
Transcript : Viatris Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-11-2023 03:00 PM	23-01-11
Viatris Inc. to Participate in 41st Annual J.P. Morgan Healthcare Conference	22-12-23	PR
Transcript : Viatris Inc., Q3 2022 Earnings Call, Nov 07, 2022	22-11-07
Viatris : Strategic Update Press Release	22-11-07	PU
Viatris : Strategic Update Presentation	22-11-07	PU
Viatris Announces Two Acquisitions to Create What it Expects to be a Leading Ophthalmology Franchise; Plans to Provide Strategic Update on its February 2022 Investor Event	22-11-07	PR
Viatris Reports Strong Third Quarter 2022 Results	22-11-07	PR
Viatris to Report Financial Results for the Third Quarter 2022 and Provide an Update on its February 28 Investor Event on November 7, 2022	22-10-24	PR
Transcript : Viatris Inc. Presents at BofA Securities Global Healthcare Conference 2022, Sep-15-2022 03:45 PM	22-09-15
Viatris Inc. to Participate in BofA Global Research Global Healthcare Conference	22-09-06	PR
Viatris : Reports Strong Second Quarter 2022 Results - Form 8-K	22-08-08	PU
Transcript : Viatris Inc., Q2 2022 Earnings Call, Aug 08, 2022	22-08-08
Viatris Reports Strong Second Quarter 2022 Results	22-08-08	PR
Viatris Inc. to Release Second Quarter 2022 Financial Results on August 8, 2022	22-07-01	PR
Transcript : Viatris Inc. Presents at Goldman Sachs 43rd Annual Global Healthcare Conference, Jun-14-2022 01:20 PM	22-06-14
Viatris to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference	22-05-20	PR
Transcript : Viatris Inc., Q1 2022 Earnings Call, May 09, 2022	22-05-09
Viatris Reports Strong First-Quarter 2022 Results	22-05-09	PR
Viatris Inc. to Release First Quarter 2022 Financial Results on May 9, 2022	22-04-08	PR

123NextSee all

Insiders

Sanjeev Narula

Currently, Sanjeev Narula is Chief Financial Officer at Viatris, Inc. In the past Mr. Narula held the position of Vice President-Finance at Pfizer Inc. and Senior VP-Finance & Business Operations at Pfizer, Inc. He received an undergraduate degree from the University of Delhi.

Amarin Narula is currently holding four director positions in different companies, including Grande Asset Hotels & Property Public Co. Ltd., Royal Orchid Hotel (Thailand) Public Co., Ltd., Sheraton Royal Orchid Co., Ltd., and Thai Royal Orchid Real Estate Ltd.
He started his career in 2002 and has been working in the hospitality industry since then.
He completed his undergraduate degree from Boston University.

M. S. Narula

Prayag Narula

Dansansing Narula

No results for this search